1. U.S. Food and Drug Administration, Investigational Device Exemption. Inclusion criteria. Maverick™ total disc replacement pivotal study, IDE G010354.
2. The indications for lumbar and cervical disc replacement;McAfee;Spine J,2004
3. Osteoarthritis of the facet joints: accuracy of oblique radiographic assessment;Panthria;Radiology,1987
4. McAfee PC. Revisability of the Charité™ artificial disc replacement-Analysis of 347 patients enrolled in the U.S. IDE study of the Charité™ Artificial Disc. Presented at the Fifth Annual Meeting of the Spinal Arthroplasty Society Meeting, May 4-7, 2005, New York.
5. Tropiano P. Strategy for lumbar total disc replacement revision and salvage. Presented at the Fifth Annual Meeting of the Spinal Arthroplasty Society Meeting, May 4-7, 2005, New York.